Pectin
As of the edition of 20 October 2026, Pectin is a drug: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Unknown
- Brand name
- Diarrhoesan
- Approvals on record
- 2 in 2 regions
- Holder of the most recent approval
- Dr. Loges
- Registered trials
- 9, 3 stopped early
- Disease areas
- Digestive system; Lungs and airways; Nutrition and metabolism; Pregnancy and women's health; Urinary and reproductive
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 2 | 1 | 1 | 0 |
| Phase 2 | 5 | 2 | 0 | 2 |
| Phase 3 | 2 | 1 | 0 | 1 |
| All trials | 9 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio | Lead sponsor of trials | 2014 to now |
| L | Lead sponsor of trials | 2015 to now |